NCT06495931

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

A Single-center, Single-arm, Open, Fixed-sequence, Self-controlled Study of the Pharmacokinetic Effects of HRS-1780, Henagliflozin, Metformin, and HRS-7535 in Healthy Subjects

• Status: Not Yet Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Shandong Suncadia Medicine Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.

Conditions

• Type 2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	HRS-1780 tablets	HRS-1780 tablets, three times
DRUG	HR20033 tablets	HR20033 tablets, nine times
DRUG	HRS-7535 tablets	HRS-7535 tablets ，three times or nine times

Timeline

• Start date: 2024-07-01
• Primary completion: 2024-07-31
• Completion: 2024-07-31
• First posted: 2024-07-11
• Last updated: 2024-07-11

Locations

1 site across 1 country: China